CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ciprofloxacin hydrochloride; hydrocortisone and what is the scope of freedom to operate?
Ciprofloxacin hydrochloride; hydrocortisone
is the generic ingredient in one branded drug marketed by Sandoz and is included in one NDA. Additional information is available in the individual branded drug profile pages.Three suppliers are listed for this compound.
Summary for CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Clinical Trials: | 4 |
DailyMed Link: | CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE at DailyMed |
Recent Clinical Trials for CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alphacait, LLC | Phase 2 |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Federal University of São Paulo | Phase 4 |
See all CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE clinical trials
Pharmacology for CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
Drug Class | Corticosteroid Fluoroquinolone Antibacterial Quinolone Antimicrobial |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists Cytochrome P450 1A2 Inhibitors |
US Patents and Regulatory Information for CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Sandoz | CIPRO HC | ciprofloxacin hydrochloride; hydrocortisone | SUSPENSION/DROPS;OTIC | 020805-001 | Feb 10, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.